Not applicableStudy completedNCT02574676What this trial is testingQuality of Life (QOL) Registry for Patients With AL AmyloidosisWho this might be right forAL AmyloidosisAmyloidosis Prothena Biosciences Ltd. 343
Testing effectiveness (Phase 2)Study completedNCT04617925What this trial is testingBelantamab Mafodotin in Patients With Relapsed or Refractory AL AmyloidosisWho this might be right forAL Amyloidosis Stichting European Myeloma Network 35
Testing effectiveness (Phase 2)Ended earlyNCT03154047What this trial is testingStudy in Subjects With Light Chain (AL) AmyloidosisWho this might be right forAL Amyloidosis Prothena Biosciences Ltd. 80
Early research (Phase 1)WithdrawnNCT05692908What this trial is testingAn Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL AmyloidosisWho this might be right forLight Chain (AL) Amyloidosis Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT01194791What this trial is testingLendexal in Patients With Primary Systemic Amyloidosis (AL) Newly DiagnosedWho this might be right forPrimary Systemic Amyloidosis PETHEMA Foundation 30
Post-approval studies (Phase 4)Looking for participantsNCT06998875What this trial is testingA Prospective Cohort Study on Primary Cutaneous AmyloidosisWho this might be right forPrimary Cutaneous Amyloidosis Army Medical University, China 56
Early research (Phase 1)Ended earlyNCT02603172What this trial is testingA Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic AmyloidosisWho this might be right forAmyloidosis GlaxoSmithKline 23
Early research (Phase 1)Study completedNCT00004232What this trial is testingBone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Northwestern University
Large-scale testing (Phase 3)Study completedNCT00666211What this trial is testingOpioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Vanderbilt-Ingram Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT00003853What this trial is testing4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT02207556What this trial is testingDoxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis TrialWho this might be right forPrimary Systemic Amyloidosis Medical College of Wisconsin 32
Not applicableStudy completedNCT01164241What this trial is testingNatural History of Severe Allergic Inflammation and ReactionsWho this might be right forPGM3 DeficiencyEosinophilic and/or Atopic DermatitisOSMR Deficiency+2 more National Institute of Allergy and Infectious Diseases (NIAID) 945
Large-scale testing (Phase 3)Study completedNCT01078454What this trial is testingMelphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain AmyloidosisWho this might be right forLight Chain Deposition DiseasePrimary Systemic Amyloidosis National Cancer Institute (NCI) 11
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Testing effectiveness (Phase 2)Study completedNCT00002849What this trial is testingS9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic AmyloidosisWho this might be right forMultiple Myeloma SWOG Cancer Research Network 93
Testing effectiveness (Phase 2)WithdrawnNCT01531751What this trial is testingHigh Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal DiseaseWho this might be right forPrimary Amyloidosis of Light Chain Type Fondazione IRCCS Policlinico San Matteo di Pavia
Early research (Phase 1)Active Not RecruitingNCT02909036What this trial is testingStudy of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.Who this might be right forMultiple MyelomaAmyloidosis Memorial Sloan Kettering Cancer Center 46
Not applicableStudy completedNCT02055534What this trial is testingNutritional Counseling in Systemic Immunoglobulin Light-chain AmyloidosisWho this might be right forAmyloidosis Fondazione IRCCS Policlinico San Matteo di Pavia 144
Large-scale testing (Phase 3)Looking for participantsNCT06963216What this trial is testingA Study Investigating Coagadex in the Treatment AFXD Associated With AL AmyloidosisWho this might be right forAcquired Factor X Deficiency Kedrion S.p.A. 15
Testing effectiveness (Phase 2)Looking for participantsNCT05145816What this trial is testingPhase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL AmyloidosisWho this might be right forAL AmyloidosisAmyloidosis University of Texas Southwestern Medical Center 37